Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 7 de 7
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
PLoS One ; 16(11): e0259104, 2021.
Artigo em Inglês | MEDLINE | ID: mdl-34762657

RESUMO

Cestodes are platyhelminth parasites with a wide range of hosts that cause neglected diseases. Neurotransmitter signaling is of critical importance for these parasites which lack circulatory, respiratory and digestive systems. For example, serotonin (5-HT) and serotonergic G-protein coupled receptors (5-HT GPCRs) play major roles in cestode motility, development and reproduction. In previous work, we deorphanized a group of 5-HT7 type GPCRs from cestodes. However, little is known about another type of 5-HT GPCR, the 5-HT1 clade, which has been studied in several invertebrate phyla but not in platyhelminthes. Three putative 5-HT GPCRs from Echinococcus canadensis, Mesocestoides vogae (syn. M. corti) and Hymenolepis microstoma were cloned, sequenced and bioinformatically analyzed. Evidence grouped these new sequences within the 5-HT1 clade of GPCRs but differences in highly conserved GPCR motifs were observed. Transcriptomic analysis, heterologous expression and immunolocalization studies were performed to characterize the E. canadensis receptor, called Eca-5-HT1a. Functional heterologous expression studies showed that Eca-5-HT1a is highly specific for serotonin. 5-Methoxytryptamine and α-methylserotonin, both known 5-HT GPCR agonists, give stimulatory responses whereas methysergide, a known 5-HT GPCR ligand, give an antagonist response in Eca-5-HT1a. Mutants obtained by the substitution of key predicted residues resulted in severe impairment of receptor activity, confirming that indeed, these residues have important roles in receptor function. Immunolocalization studies on the protoscolex stage from E. canadensis, showed that Eca-5-HT1a is localized in branched fibers which correspond to the nervous system of the parasite. The patterns of immunoreactive fibers for Eca-5-HT1a and for serotonin were intimately intertwined but not identical, suggesting that they are two separate groups of fibers. These data provide the first functional, pharmacological and localization report of a serotonergic receptor that putatively belongs to the 5-HT1 type of GPCRs in cestodes. The serotonergic GPCR characterized here may represent a new target for antiparasitic intervention.


Assuntos
Cestoides/metabolismo , Proteínas de Helminto/metabolismo , Sistema Nervoso/metabolismo , Receptores 5-HT1 de Serotonina/metabolismo , Sequência de Aminoácidos , Animais , Echinococcus/metabolismo , Regulação da Expressão Gênica/efeitos dos fármacos , Proteínas de Helminto/química , Proteínas de Helminto/genética , Humanos , Hymenolepis/metabolismo , Receptores 5-HT1 de Serotonina/química , Receptores 5-HT1 de Serotonina/genética , Alinhamento de Sequência , Antagonistas da Serotonina/farmacologia , Agonistas do Receptor de Serotonina/farmacologia
2.
Nature ; 592(7854): 469-473, 2021 04.
Artigo em Inglês | MEDLINE | ID: mdl-33762731

RESUMO

Serotonin, or 5-hydroxytryptamine (5-HT), is an important neurotransmitter1,2 that activates the largest subtype family of G-protein-coupled receptors3. Drugs that target 5-HT1A, 5-HT1D, 5-HT1E and other 5-HT receptors are used to treat numerous disorders4. 5-HT receptors have high levels of basal activity and are subject to regulation by lipids, but the structural basis for the lipid regulation and basal activation of these receptors and the pan-agonism of 5-HT remains unclear. Here we report five structures of 5-HT receptor-G-protein complexes: 5-HT1A in the apo state, bound to 5-HT or bound to the antipsychotic drug aripiprazole; 5-HT1D bound to 5-HT; and 5-HT1E in complex with a 5-HT1E- and 5-HT1F-selective agonist, BRL-54443. Notably, the phospholipid phosphatidylinositol 4-phosphate is present at the G-protein-5-HT1A interface, and is able to increase 5-HT1A-mediated G-protein activity. The receptor transmembrane domain is surrounded by cholesterol molecules-particularly in the case of 5-HT1A, in which cholesterol molecules are directly involved in shaping the ligand-binding pocket that determines the specificity for aripiprazol. Within the ligand-binding pocket of apo-5-HT1A are structured water molecules that mimic 5-HT to activate the receptor. Together, our results address a long-standing question of how lipids and water molecules regulate G-protein-coupled receptors, reveal how 5-HT acts as a pan-agonist, and identify the determinants of drug recognition in 5-HT receptors.


Assuntos
Microscopia Crioeletrônica , Ligantes , Lipídeos , Receptores 5-HT1 de Serotonina/metabolismo , Receptores 5-HT1 de Serotonina/ultraestrutura , Apoproteínas/química , Apoproteínas/metabolismo , Apoproteínas/ultraestrutura , Aripiprazol/metabolismo , Aripiprazol/farmacologia , Sítios de Ligação , Colesterol/farmacologia , Proteínas Heterotriméricas de Ligação ao GTP/química , Proteínas Heterotriméricas de Ligação ao GTP/metabolismo , Proteínas Heterotriméricas de Ligação ao GTP/ultraestrutura , Humanos , Modelos Moleculares , Fosfatos de Fosfatidilinositol/química , Fosfatos de Fosfatidilinositol/metabolismo , Fosfatos de Fosfatidilinositol/farmacologia , Receptor 5-HT1A de Serotonina/química , Receptor 5-HT1A de Serotonina/metabolismo , Receptor 5-HT1A de Serotonina/ultraestrutura , Receptores 5-HT1 de Serotonina/química , Agonistas do Receptor 5-HT1 de Serotonina/química , Agonistas do Receptor 5-HT1 de Serotonina/metabolismo , Agonistas do Receptor 5-HT1 de Serotonina/farmacologia , Água/química
3.
Br J Pharmacol ; 159(7): 1450-62, 2010 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-20233210

RESUMO

BACKGROUND AND PURPOSE: 5-Hydroxytryptamine (5-HT) has been shown to control and modulate many physiological and behavioural functions in insects. In this study, we report the cloning and pharmacological properties of a 5-HT(1) receptor of an insect model for neurobiology, physiology and pharmacology. EXPERIMENTAL APPROACH: A cDNA encoding for the Periplaneta americana 5-HT(1) receptor was amplified from brain cDNA. The receptor was stably expressed in HEK 293 cells, and the functional and pharmacological properties were determined in cAMP assays. Receptor distribution was investigated by RT-PCR and by immunocytochemistry using an affinity-purified polyclonal antiserum. KEY RESULTS: The P. americana 5-HT(1) receptor (Pea5-HT(1)) shares pronounced sequence and functional similarity with mammalian 5-HT(1) receptors. Activation with 5-HT reduced adenylyl cyclase activity in a dose-dependent manner. Pea5-HT(1) was expressed as a constitutively active receptor with methiothepin acting as a neutral antagonist, and WAY 100635 as an inverse agonist. Receptor mRNA was present in various tissues including brain, salivary glands and midgut. Receptor-specific antibodies showed that the native protein was expressed in a glycosylated form in membrane samples of brain and salivary glands. CONCLUSIONS AND IMPLICATIONS: This study marks the first pharmacological identification of an inverse agonist and a neutral antagonist at an insect 5-HT(1) receptor. The results presented here should facilitate further analyses of 5-HT(1) receptors in mediating central and peripheral effects of 5-HT in insects.


Assuntos
Periplaneta/metabolismo , Receptores 5-HT1 de Serotonina/efeitos dos fármacos , Antagonistas da Serotonina/farmacologia , Sequência de Aminoácidos , Animais , Sequência de Bases , Linhagem Celular , Clonagem Molecular , Primers do DNA , DNA Complementar , Humanos , Imuno-Histoquímica , Dados de Sequência Molecular , Periplaneta/genética , Filogenia , Receptores 5-HT1 de Serotonina/química , Receptores 5-HT1 de Serotonina/genética , Reação em Cadeia da Polimerase Via Transcriptase Reversa , Homologia de Sequência de Aminoácidos
4.
J Chem Inf Model ; 48(5): 997-1013, 2008 May.
Artigo em Inglês | MEDLINE | ID: mdl-18470978

RESUMO

The Quantitative Structure-Activity Relationship (QSAR) approach has been applied to model binding affinity and receptor subtype selectivity of human 5HT1E and 5HT1F receptor-ligands. The experimental data were obtained from the PDSP Ki Database. Several descriptor types and data-mining approaches have been used in the context of combinatorial QSAR modeling. Data mining approaches included k Nearest Neighbor, Automated Lazy Learning (ALL), and PLS; descriptor types included MolConnZ, MOE, DRAGON, Frequent Subgraphs (FSG), and Molecular Hologram Fingerprints (MHFs). Highly predictive QSAR models were generated for all three data sets (i.e., for ligands of both receptor subtypes and for subtype selectivity), and different individual techniques were proved best in each case. For real value activity data available for 5HT1E and 5HT1F ligand binding, models were characterized by leave-one-out cross-validated R(2) (q(2)) for the training sets and predictive R(2) values for the test sets. The best models for 5HT1E ligands were obtained with the kNN approach combined with MolConnZ descriptors (q(2)=0.69, R(2)=0.92); for 5HT1F ligands ALL QSAR method using MolConnZ descriptors gave the best results (R(2)=0.92). Rigorously validated classification models were also developed for the 5HT1E/5HT1F subtype selectivity data set with high correct classification accuracy for both training (CCRtrain=0.88) and test (CCRtest=1.00) sets using kNN with MolConnZ descriptors. The external predictive power of QSAR models was further validated by virtual screening of The Scripps Research Institute (TSRI) screening library to recover 5HT1E agonists and antagonists (not present in the original PDSP data set) with high enrichment factors. The successful development of externally predictive and interpretative QSAR models affords further design and discovery of novel subtype specific GPCR agents.


Assuntos
Técnicas de Química Combinatória/métodos , Modelos Biológicos , Relação Quantitativa Estrutura-Atividade , Receptores 5-HT1 de Serotonina/química , Receptores 5-HT1 de Serotonina/metabolismo , Avaliação Pré-Clínica de Medicamentos , Análise dos Mínimos Quadrados , Ligantes , Transtornos de Enxaqueca/tratamento farmacológico , Reprodutibilidade dos Testes , Especificidade por Substrato
5.
J Exp Biol ; 211(Pt 1): 92-105, 2008 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-18083737

RESUMO

Serotonin (5-HT) plays important roles in the maintenance and modulation of neural systems throughout the animal kingdom. The actions of 5-HT have been well characterized for several crustacean model circuits; however, a dissection of the serotonergic transduction cascades operating in these models has been hampered by the lack of pharmacological tools for invertebrate receptors. Here we provide pharmacological profiles for two 5-HT receptors from the swamp crayfish, Procambarus clarkii: 5-HT(2beta) and 5-HT(1alpha). In so doing, we also report the first functional expression of a crustacean 5-HT(1) receptor, and show that it inhibits accumulation of cAMP. The drugs mCPP and quipazine are 5-HT(1alpha) agonists and are ineffective at 5-HT(2beta). Conversely, methiothepin and cinanserin are antagonists of 5-HT(2beta) but do not block 5-HT(1alpha). A comparison of these two receptors with their orthologs from the California spiny lobster, Panulirus interruptus, indicates conservation of protein structure, signaling and pharmacology. This conservation extends beyond crustacean infraorders. The signature residues that form the ligand-binding pocket in mammalian 5-HT receptors are found in the crustacean receptors. Similarly, the protein domains involved in G protein coupling are conserved between the two crustacean receptors and other characterized arthropod and mammalian 5-HT receptors. Considering the apparent conservation of pharmacological properties between crustacean 5-HT receptors, these tools could be applicable to related crustacean physiological preparations.


Assuntos
Astacoidea/metabolismo , Sequência Conservada , Palinuridae/metabolismo , Receptores 5-HT1 de Serotonina/química , Receptores 5-HT2 de Serotonina/química , Transdução de Sinais , Aminas , Sequência de Aminoácidos , Animais , Astacoidea/efeitos dos fármacos , Linhagem Celular , Cães , Relação Dose-Resposta a Droga , Humanos , Camundongos , Dados de Sequência Molecular , Palinuridae/efeitos dos fármacos , Receptores 5-HT1 de Serotonina/metabolismo , Receptores 5-HT2 de Serotonina/metabolismo , Análise de Sequência de Proteína , Antagonistas da Serotonina/farmacologia , Agonistas do Receptor de Serotonina/farmacologia , Transdução de Sinais/efeitos dos fármacos
6.
Eur J Med Chem ; 43(8): 1696-705, 2008 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-18006194

RESUMO

In this publication we are describing synthesis, binding properties, and receptor docking of 4-halo-6-[2-(4-arylpiperazin-1-yl)ethyl]-1H-benzimidazoles, a new compounds with potential antipsychotics properties. Affinity towards the dopamine D(1)-like and D(2)-like, and serotonin 5-HT(1A) receptors was evaluated using the radioligand binding assays. All compounds tested had affinity for the D(2)-like and 5-HT(1A) receptors, but were inactive towards the D(1)-like receptor. Halogenated 6-[2-(4-arylpiperazin-1-yl)ethyl]-1H-benzimidazoles showed higher affinity compared to their nonhalogenated congeners. In silico docking analysis of selected ligands was performed in order to explain the results of binding assays. Our analysis suggests that stabilizing interactions between the halogen atom at the benzimidazole ring and the Ser-122 of the D(2)-like and Trp-358 of the 5-HT(1A) receptor. Energy contributions for these interactions were calculated using the ab initio method.


Assuntos
Benzimidazóis/síntese química , Benzimidazóis/farmacologia , Halogênios/química , Piperazinas/química , Receptores de Dopamina D2/química , Receptores 5-HT1 de Serotonina/química , Benzimidazóis/química , Simulação por Computador , Humanos , Ligantes , Modelos Moleculares , Estrutura Molecular , Piperazina , Receptores de Dopamina D2/metabolismo , Receptores 5-HT1 de Serotonina/metabolismo
7.
Bioorg Med Chem Lett ; 16(1): 150-3, 2006 Jan 01.
Artigo em Inglês | MEDLINE | ID: mdl-16216506

RESUMO

The discovery of a new series of selective and high-affinity alpha(1)-adrenoceptor (alpha(1)-AR) ligands, characterized by a 1H-pyrrolo[2,3-d]-pyrimidine-2,4(3H,7H)-dione system, is described in this paper. Some synthesized compounds, including 20, 22, and 30, displayed affinity in the nanomolar range for alpha(1)-ARs and substantial selectivity with respect to 5-HT(1A) and dopaminergic D(1) and D(2) receptors. Functional assays, performed on selected derivatives, showed antagonistic properties.


Assuntos
Piperazinas/farmacologia , Pirróis/química , Receptores Adrenérgicos alfa 1/química , Cloro/química , Dopaminérgicos/metabolismo , Relação Dose-Resposta a Droga , Humanos , Cinética , Ligantes , Espectroscopia de Ressonância Magnética , Modelos Químicos , Piperazinas/química , Ligação Proteica , Pirimidinonas/química , Receptores Adrenérgicos alfa 1/metabolismo , Receptores de Serotonina/química , Receptores 5-HT1 de Serotonina/química , Fatores de Tempo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...